Ocugen (OCGN) Operating Margin (2014 - 2026)
Ocugen posted quarterly Operating Margin of 1163.67% for Q1 2026, down 18453.0% year-on-year from N/an in Q1 2025, and down 113.21% on a QoQ basis from 8805.7% in Q4 2025.
Ocugen (OCGN) has 7 years of Operating Margin data on file, last reported at 1163.67% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 18453.0% year-over-year to 1163.67%; the trailing twelve-month figure through Mar 2026 stood at 1483.85% (down 22242.0% YoY), and the FY2025 full-year result was 1425.7%, down 7534.0% from the prior year.
- Operating Margin for Q1 2026 stood at 1163.67%, down from 8805.7% in the prior quarter.
- Across five years, Operating Margin topped out at 8805.7% in Q4 2025 and bottomed at 5388.41% in Q3 2022.
- The 5-year median for Operating Margin is 1204.73% (2024), against an average of 1539.43%.
- The widest annual swing landed in 2023, when Operating Margin sank 149809 bps; it then surged 1061722 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 2657.0% in 2022, then soared by 69 bps to 817.96% in 2023, then tumbled by 121 bps to 1811.52% in 2024, then jumped by 586 bps to 8805.7% in 2025, then plunged by 113 bps to 1163.67% in 2026.
- The last three Operating Margin figures came in at 1163.67% (Q1 2026), 8805.7% (Q4 2025), and 1005.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | -1,163.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,163.67% |
| Dec 31, 2025 | 8,805.70% |
| Sep 30, 2025 | -1,005.99% |
| Jun 30, 2025 | -1,004.73% |
| Mar 31, 2025 | -979.14% |
| Dec 31, 2024 | -1,811.52% |
| Sep 30, 2024 | -1,166.55% |
| Jun 30, 2024 | -1,353.99% |
| Mar 31, 2024 | -1,204.73% |
| Dec 31, 2023 | -817.96% |
| Sep 30, 2023 | -336.06% |
| Jun 30, 2023 | -4,853.61% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,657.00% |
| Sep 30, 2022 | -5,388.41% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -7,827.91% |
| Sep 30, 2014 | -2.30% |